Clinical Trial Detail

NCT ID NCT03814005
Title A Study of Pevonedistat in Combination With Azacitidine in Participants With Higher-risk Myelodysplastic Syndromes (HR MDS), Chronic Myelomonocytic Leukemia (CMML), or Acute Myelogenous Leukemia (AML) With Severe Renal Impairment or Mild Hepatic Impairment
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Millennium Pharmaceuticals, Inc.
Indications

myelodysplastic syndrome

chronic myelomonocytic leukemia

Therapies

Azacitidine + MLN4924

Age Groups: adult senior

No variant requirements are available.